Avanos Medical has named David Pacitti as its new chief executive officer (CEO). Pacitti will take office on April 14, 2025.

Pacitti was most recently president of Siemens Medical Solutions USA and Head of the Americas for Siemens Healthineers. There, he led the marketing, sales, service, and support function in North America and Latin America for the entire Siemens Healthineers portfolio—including medical imaging, laboratory diagnostics, therapy solutions, and services.

Before joining Siemens Healthineers in 2015, Pacitti had several leadership positions at Abbott Vascular, including division VP of U.S. commercial operations, sales and marketing. There he oversaw the company’s North American business and played a crucial role in the launch of Abbott Vascular’s first drug-eluting stent franchise and structural heart franchise. Pacitti joined Abbott Vascular through its acquisition of Guidant, where he had roles of growing responsibility from 1995 to 2006.

He’s the chair of the AdvaMed Medical Imaging Technology Division’s board of directors and on the boards for Orchestra BioMed and the Siemens Foundation. He is also a member of the CEO Council for Growth at the Chamber of Commerce for Greater Philadelphia, the Children’s Hospital of Philadelphia Corporate Council, the Medical University of South Carolina (MUSC) President’s Advisory Group, and the NextGen Advisory Board for the University of Missouri.

“We are delighted to welcome David Pacitti as the new CEO of Avanos Medical,” said Gary Blackford, chair of the Avanos board of directors. “David’s extensive industry expertise, leadership acumen, and strategic vision make him the ideal choice to lead Avanos in its next phase of growth and success.”

“I am honored to lead such a dynamic organization,” added Pacitti. “Avanos has a strong portfolio of market-leading products and is committed to delivering breakthrough medical device solutions that improve quality of life. I look forward to building on our success and driving long-term value for our stakeholders.”